Form 8-K
8-K — CareCloud, Inc.
Accession: 0001493152-26-036255
Filed: 2026-08-06
Period: 2026-08-06
CIK: 0001582982
SIC: 7372 (SERVICES-PREPACKAGED SOFTWARE)
Item: Results of Operations and Financial Condition
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — form8-k.htm (Primary)
EX-99.1 (ex99-1.htm)
EX-99.2 (ex99-2.htm)
GRAPHIC (ex99-2_001.jpg)
GRAPHIC (ex99-2_002.jpg)
GRAPHIC (ex99-2_003.jpg)
GRAPHIC (ex99-2_004.jpg)
GRAPHIC (ex99-2_005.jpg)
GRAPHIC (ex99-2_006.jpg)
GRAPHIC (ex99-2_007.jpg)
GRAPHIC (ex99-2_008.jpg)
GRAPHIC (ex99-2_009.jpg)
GRAPHIC (ex99-2_010.jpg)
GRAPHIC (ex99-2_011.jpg)
GRAPHIC (ex99-2_012.jpg)
GRAPHIC (ex99-2_013.jpg)
GRAPHIC (ex99-2_014.jpg)
GRAPHIC (ex99-2_015.jpg)
GRAPHIC (ex99-2_016.jpg)
GRAPHIC (ex99-2_017.jpg)
GRAPHIC (ex99-2_018.jpg)
GRAPHIC (ex99-2_019.jpg)
GRAPHIC (ex99-2_020.jpg)
GRAPHIC (ex99-2_021.jpg)
GRAPHIC (ex99-2_022.jpg)
GRAPHIC (ex99-2_023.jpg)
GRAPHIC (ex99-2_024.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K
8-K (Primary)
Filename: form8-k.htm · Sequence: 1
false
0001582982
0001582982
2026-08-06
2026-08-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 6, 2026
CARECLOUD,
INC.
(Exact
name of registrant as specified in its charter)
Delaware
001-36529
22-3832302
(State
or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS
Employer
Identification No.)
7
Clyde Road, Somerset, New Jersey, 08873
(Address of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
Trading
Symbol(s)
Name
of each exchange on which registered
Common
Stock, par value $0.001 per share
CCLD
Nasdaq
Global Market
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
2.02 Results of Operations and Financial Condition.
On
August 6, 2026, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein
by reference.
The
information furnished pursuant to Item 2.02 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section,
nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended or the Exchange Act,
except as expressly set forth by specific reference in such a filing.
Item
7.01 Regulation FD Disclosure.
On
August 6, 2026, the Registrant provided slides to accompany its earnings presentation, a copy of which is attached hereto as Exhibit
99.2 and is incorporated herein by reference.
The
information furnished pursuant to Item 7.01 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section,
nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended or the Exchange Act,
except as expressly set forth by specific reference in such a filing.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
99.1
Press release dated August 6, 2026.
99.2
Slide presentation dated August 6, 2026.
104
Cover
Page Interactive Data File (embedded within the Inline XBRL document)
2
SIGNATURE(S)
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, hereunto duly authorized.
CareCloud,
Inc.
Date:
August
6, 2026
By:
/s/
Norman Roth
Norman
Roth
Interim
Chief Financial Officer and Corporate Controller
3
EX-99.1
EX-99.1
Filename: ex99-1.htm · Sequence: 2
Exhibit
99.1
CareCloud
Reports Second Quarter 2026 Results
Revenue
Grows 16%; Ninth Consecutive Quarter of Positive GAAP Net Income
SOMERSET,
N.J., August 6, 2026 (GLOBE NEWSWIRE)—CareCloud, Inc. (Nasdaq: CCLD), a leader in AI-powered healthcare technology and revenue
cycle management solutions for medical practices and health systems nationwide, today announced financial results for the quarter ended
June 30, 2026 and reaffirmed its full-year guidance.
Second
Quarter 2026 Financial Highlights:
● Revenue
of $31.9 million, compared to $27.4 million in Q2 2025
● GAAP
net income of $1.1 million, compared to $2.9 million in Q2 2025
● GAAP
EPS of $0.00 per share, compared to $0.04 per share in Q2 2025
● Adjusted
EBITDA of $5.9 million, compared to $6.5 million in Q2 2025
Year-to-date
2026 Highlights:
● Revenue
of $63.2 million, compared to $55.0 million in the same period last year
● GAAP
net income of $2.0 million, compared to $4.9 million in the same period last year
● GAAP
EPS of ($0.01) per share, compared to $0.02 per share in the same period last year
● Adjusted
EBITDA of $11.3 million, compared to $12.1 million in the same period last year
Key
Second Quarter Accomplishments:
● Compliance
and Audit-Defense Market Entry: Expanded the product portfolio through the acquisition
of Empower Healthcare & Compliance Partners, opening a new growth opportunity by bringing
trusted compliance, audit-defense, and regulatory expertise to CareCloud’s network
of more than 40,000 providers.
● Full
Redemption of Series B Preferred Stock: Completed the redemption of all outstanding Series
B Preferred Stock on May 15, 2026.
● Sustained
Profitability: Delivered the ninth consecutive quarter of positive GAAP net income.
Management
Commentary
“This
quarter we grew revenue 16%, delivered our ninth consecutive quarter of positive GAAP net
income, and entered the compliance and audit-defense market through our acquisition of Empower
Healthcare. We’re investing deliberately in what we believe defines our next phase
of growth — our AI solutions, our expanding capabilities, and the cross-sell opportunity
across our more than 40,000 providers.” — Stephen Snyder, Chief Executive
Officer, CareCloud
“Our
AI and acquisition strategies have become a single, unified growth engine. Every platform we bring into CareCloud becomes smarter, faster,
and more valuable when we layer in our AI capabilities. We are still in the early innings of unlocking the cross-sell potential across
our expanded client base, and we are increasingly seeing customers adopt our AI-enabled offerings.” — A. Hadi Chaudhry,
Chief Strategy Officer, CareCloud
“As
expected, profitability this quarter reflects deliberate investments we are making today — increased R&D spending on our AI-enabled
capabilities and increased interest expense from simplifying our capital structure through the Series B redemption — that we believe
will deliver returns over time. We expect these investments to enhance scalability, improve operational efficiency, and support long-term
margin expansion.” — Norman Roth, Interim Chief Financial Officer and Corporate Controller, CareCloud
1
2026
Outlook
The
Company is reaffirming its guidance for calendar year 2026.
For the Fiscal Year Ending December 31, 2026
Full Year 2026 Guidance
Revenue
$128 – $132 million
Adjusted EBITDA
$29
– $31 million
GAAP Net Income Per Share (EPS)
$0.20
– $0.23
Our
expectations regarding future profitability, including adjusted EBITDA and earnings-per-share guidance, are based on management’s
current beliefs and assumptions regarding, among other things, the signing and continuation of certain client and vendor relationships,
the anticipated timing and scope of client projects, and our timely execution of integration and expense-management initiatives intended
to align our cost structure with those objectives.
Conference
Call Information
CareCloud
management will host a live conference call today, August 6, 2026, at 8:30 a.m. Eastern Time to discuss second quarter 2026 results
and the Company’s 2026 strategy.
Webcast:
ir.carecloud.com/events
Dial-in
(Audio Only): 201-389-0920 | Reference: “CareCloud, Inc. Second Quarter 2026 Results Conference Call.”
Replay
Dial-in: 412-317-6671 | Access Code: 13761329 (available approximately 3 hours after the call).
About
CareCloud
CareCloud
brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase
financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count
on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products
and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence,
patient experience management (PXM) and digital health, at carecloud.com.
Follow
CareCloud on LinkedIn, X and Facebook.
For
additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management
team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.
Contacts
Company
Contact:
Investor
Contact:
Norman
Roth
Stephen
Snyder
Interim
Chief Financial Officer and Corporate Controller
Chief
Executive Officer
CareCloud,
Inc.
CareCloud,
Inc.
nroth@carecloud.com
ir@carecloud.com
2
Use
of Non-GAAP Financial Measures
In
our earnings releases, prepared remarks, conference calls, slide presentations and webcasts, we use and discuss non-GAAP financial measures,
as defined by SEC Regulation G. The GAAP financial measure most directly comparable to each non-GAAP financial measure used or discussed
and a reconciliation of the differences between each non-GAAP financial measure and the comparable GAAP financial measure, are included
in this press release after the condensed consolidated financial statements. Our earnings press releases containing such non-GAAP reconciliations
can be found in the Investor Relations section of our web site at ir.carecloud.com.
Forward-Looking
Statements
This
press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities
Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial
performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,”
“will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,”
“goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,”
“forecasts,” “predicts,” “possible,” “potential,” “target,” or “continue”
or the negative of these terms or other comparable terminology.
Our
operations involve risks and uncertainties, many of which are outside our control and any one of which, or a combination of which, could
materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking
statements in this press release include, without limitation, statements reflecting management’s expectations for future financial
performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial
performance and business activities and the expected results from the integration of our acquisitions.
These
forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are
uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s)
actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance
expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time and it is not possible
for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation,
risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and
existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and
properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop
new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’
products and services competitive with ours, manage and keep our information systems secure and other important risks and uncertainties
referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange
Commission.
The
statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on
its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events
that occur or circumstances that exist after the date on which they were made.
3
CARECLOUD,
INC.
CONDENSED
CONSOLIDATED BALANCE SHEETS
AS
OF JUNE 30, 2026 AND DECEMBER 31, 2025
($
in thousands, except share and per share amounts)
June 30, 2026
December 31, 2025
(Unaudited)
ASSETS
Current assets:
Cash
$ 13,395
$ 3,117
Restricted cash
-
500
Accounts receivable - net
14,117
15,062
Contract asset
3,426
3,664
Inventory
471
507
Current assets - related party
16
16
Prepaid expenses and other current assets
2,758
2,872
Total current assets
34,183
25,738
Property and equipment - net
7,259
7,775
Operating lease right-of-use assets
4,864
3,106
Intangible assets - net
14,929
18,968
Goodwill
31,835
31,442
Other assets
779
569
TOTAL ASSETS
$ 93,849
$ 87,598
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$ 6,071
$ 6,937
Accrued compensation
3,846
4,136
Accrued expenses
5,943
5,970
Operating lease liability (current portion)
1,573
927
Deferred revenue (current portion)
4,507
4,148
Term loans and other (current portion)
10,756
728
Contingent consideration (current portion)
400
909
Dividend payable
392
668
Total current liabilities
33,488
24,423
Term loans and other
29,223
441
Borrowings under line of credit
9,000
-
Contingent consideration
290
232
Operating lease liability
3,462
2,187
Deferred revenue
934
809
Deferred tax liability
50
-
Total liabilities
76,447
28,092
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY:
Preferred stock, $0.001 par value - authorized 7,000,000 shares. Series A, issued and outstanding 984,530 shares at June 30, 2026 and December 31, 2025. Series B, issued and outstanding 0 and 1,511,372 shares at June 30, 2026 and December 31, 2025, respectively.
1
2
Common stock, $0.001 par value - authorized 85,000,000 shares. Issued 43,234,658 and 43,178,748 shares at June 30, 2026 and December 31, 2025, respectively. Outstanding 42,493,859 and 42,437,949 shares at June 30, 2026 and December 31, 2025, respectively.
43
43
Additional paid-in capital
75,735
119,936
Accumulated deficit
(53,788 )
(55,832 )
Accumulated other comprehensive loss
(3,927 )
(3,981 )
Less: 740,799 common shares held in treasury, at cost at June 30, 2026 and December 31, 2025
(662 )
(662 )
Total shareholders’ equity
17,402
59,506
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
$ 93,849
$ 87,598
4
CARECLOUD,
INC.
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
FOR
THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025
($
in thousands, except share and per share amounts)
Three Months Ended June 30,
Six Months Ended June 30,
2026
2025
2026
2025
NET REVENUE
$ 31,880
$ 27,377
$ 63,150
$ 55,009
OPERATING EXPENSES:
Direct operating costs
17,457
14,480
34,307
29,944
Selling and marketing
1,300
1,118
2,714
2,249
General and administrative
5,370
4,358
10,866
8,690
Research and development
2,194
1,020
4,610
2,255
Change in contingent consideration
(34 )
-
23
-
Depreciation and amortization
3,731
3,382
7,768
6,719
Restructuring costs
-
23
-
137
Total operating expenses
30,018
24,381
60,288
49,994
OPERATING INCOME
1,862
2,996
2,862
5,015
OTHER:
Interest income
73
51
83
93
Interest expense
(815 )
(68 )
(873 )
(126 )
Other income (expense) - net
104
(35 )
126
(49 )
INCOME BEFORE PROVISION FOR INCOME TAXES
1,224
2,944
2,198
4,933
Income tax provision
102
42
154
83
NET INCOME
$ 1,122
$ 2,902
$ 2,044
$ 4,850
Preferred stock dividend
941
1,365
2,306
4,176
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS
$ 181
$ 1,537
$ (262 )
$ 674
Net income (loss) per common share: basic and diluted
$ 0.00
$ 0.04
$ (0.01 )
$ 0.02
Weighted-average common shares used to compute basic and diluted loss per share
42,493,449
42,321,629
42,482,758
33,118,912
5
CARECLOUD,
INC.
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
FOR
THE SIX MONTHS ENDED JUNE 30, 2026 AND 2025
($
in thousands)
2026
2025
OPERATING ACTIVITIES:
Net income
$ 2,044
$ 4,850
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
7,858
6,855
Lease amortization
896
901
Provision for expected credit losses
118
169
Provision for deferred income taxes
50
-
Foreign exchange loss
15
1
Interest accretion
208
219
Change in contingent consideration
23
-
Stock-based compensation expense
128
219
Changes in operating assets and liabilities:
Accounts receivable
827
(958 )
Contract asset
238
411
Inventory
36
51
Other assets
73
(838 )
Accounts payable and other liabilities
(2,146 )
377
Deferred revenue
316
264
Net cash provided by operating activities
10,684
12,521
INVESTING ACTIVITIES:
Purchases of property and equipment
(937 )
(1,786 )
Capitalized software and other intangible assets
(1,620 )
(1,677 )
Payment for acquisitions
(681 )
(40 )
Net cash used in investing activities
(3,238 )
(3,503 )
FINANCING ACTIVITIES:
Preferred stock dividends paid
(6,436 )
(3,317 )
Payment of contingent consideration
(618 )
-
Payment of tax withholding on stock issued to employees
(1 )
(22 )
Proceeds from term loan
39,739
-
Repayments of notes payable and term loan
(1,191 )
(355 )
Redemption of Series B Preferred Stock
(38,169 )
-
Proceeds from line of credit
9,000
-
Net cash provided by (used in) financing activities
2,324
(3,694 )
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND RESTRICTED CASH
8
(29 )
NET INCREASE IN CASH AND RESTRICTED CASH
9,778
5,295
CASH AND RESTRICTED CASH - Beginning of the period
3,617
5,145
CASH - End of the period
$ 13,395
$ 10,440
SUPPLEMENTAL NONCASH INVESTING AND FINANCING ACTIVITIES:
Conversion of Series A Preferred Stock and accrued dividends to common stock
$ -
$ 2,435
Dividends declared, not paid
$ 392
$ 714
SUPPLEMENTAL INFORMATION - Cash paid during the period for:
Income taxes
$ 158
$ 144
Interest
$ 517
$ 44
6
RECONCILIATION
OF NON-GAAP FINANCIAL MEASURES
TO
COMPARABLE GAAP MEASURES (UNAUDITED)
The
following is a reconciliation of the non-GAAP financial measures used by us to describe our financial results determined in accordance
with accounting principles generally accepted in the United States of America (“GAAP”). An explanation of these measures
is also included below under the heading “Explanation of Non-GAAP Financial Measures.”
While
management believes that these non-GAAP financial measures provide useful supplemental information to investors regarding the underlying
performance of our business operations, investors are reminded to consider these non-GAAP measures in addition to, and not as a substitute
for, financial performance measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures
may be different from non-GAAP measures used by other companies, and management may utilize other measures to illustrate performance
in the future. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our results of operations
as determined in accordance with GAAP.
Adjusted
EBITDA to GAAP Net Income
Set
forth below is a reconciliation of our “adjusted EBITDA” to our GAAP net income.
Three Months Ended June 30,
Six Months Ended June 30,
2026
2025
2026
2025
($ in thousands)
Net revenue
$ 31,880
$ 27,377
$ 63,150
$ 55,009
GAAP net income
1,122
2,902
2,044
4,850
Provision for income taxes
102
42
154
83
Net interest expense
742
17
790
33
Foreign exchange loss / other expense
54
41
86
60
Stock-based compensation expense
64
111
128
219
Depreciation and amortization
3,731
3,382
7,768
6,719
Change in contingent consideration
(34 )
-
23
-
Transaction and integration costs
166
11
324
23
Restructuring costs
-
23
-
137
Adjusted EBITDA
$ 5,947
$ 6,529
$ 11,317
$ 12,124
7
Non-GAAP
Adjusted Operating Income to GAAP Operating Income
Set
forth below is a reconciliation of our non-GAAP “adjusted operating income” and non-GAAP “adjusted operating margin”
to our GAAP operating income and GAAP operating margin.
Three Months Ended June 30,
Six Months Ended June 30,
2026
2025
2026
2025
($ in thousands)
Net revenue
$ 31,880
$ 27,377
$ 63,150
$ 55,009
GAAP net income
1,122
2,902
2,044
4,850
Provision for income taxes
102
42
154
83
Net interest expense
742
17
790
33
Other (income) expense - net
(104 )
35
(126 )
49
GAAP operating income
1,862
2,996
2,862
5,015
GAAP operating margin
5.8 %
10.9 %
4.5 %
9.1 %
Stock-based compensation expense
64
111
128
219
Amortization of purchased intangible assets
945
193
1,873
282
Transaction and integration costs
166
11
324
23
Change in contingent consideration
(34 )
-
23
-
Restructuring costs
-
23
-
137
Non-GAAP adjusted operating income
$ 3,003
$ 3,334
$ 5,210
$ 5,676
Non-GAAP adjusted operating margin
9.4 %
12.2 %
8.3 %
10.3 %
Non-GAAP
Adjusted Net Income to GAAP Net Income
Set
forth below is a reconciliation of our non-GAAP “adjusted net income” and non-GAAP “adjusted net income per share”
to our GAAP net income and GAAP net income per share.
Three Months Ended June 30,
Six Months Ended June 30,
2026
2025
2026
2025
($ in thousands )
GAAP net income
$ 1,122
$ 2,902
$ 2,044
$ 4,850
Foreign exchange loss / other expense
54
41
86
60
Stock-based compensation expense
64
111
128
219
Amortization of purchased intangible assets
945
193
1,873
282
Transaction and integration costs
166
11
324
23
Change in contingent consideration
(34 )
-
23
-
Restructuring costs
-
23
-
137
Income tax expense related to goodwill
50
-
50
-
Non-GAAP adjusted net income
$ 2,367
$ 3,281
$ 4,528
$ 5,571
8
Three Months Ended June 30,
Six Months Ended June 30,
2026
2025
2026
2025
GAAP net income (loss) attributable to common shareholders, per share
$ 0.00
$ 0.04
$ (0.01 )
$ 0.02
Impact of preferred stock dividend
0.03
0.03
0.06
0.09
Net income per end-of-period share
0.03
0.07
0.05
0.11
Foreign exchange loss / other expense
0.00
0.00
0.00
0.00
Stock-based compensation expense
0.01
0.00
0.01
0.01
Amortization of purchased intangible assets
0.02
0.00
0.04
0.01
Transaction and integration costs
0.00
0.00
0.01
0.00
Change in contingent consideration
0.00
0.00
0.00
-
Restructuring costs
-
0.00
-
0.00
Income tax expense related to goodwill
0.00
-
0.00
-
Non-GAAP adjusted earnings per share
$ 0.06
$ 0.07
$ 0.11
$ 0.13
End-of-period common shares
42,493,859
42,322,039
42,493,859
42,322,039
For
purposes of determining non-GAAP adjusted earnings per share, the Company used the number of common shares outstanding as of June 30,
2026 and 2025. Non-GAAP adjusted earnings per share does not take into account dividends declared or earned on preferred stock.
Net
cash provided by operating activities to free cash flow
Set
forth below is a reconciliation of our non-GAAP “free cash flow” to our GAAP net cash provided by operating activities.
Three Months Ended June 30,
Six Months Ended June 30,
2026
2025
2026
2025
($ in thousands)
Net cash provided by operating activities
$ 7,073
$ 7,408
$ 10,684
$ 12,521
Purchases of property and equipment
(525 )
(1,162 )
(937 )
(1,786 )
Capitalized software and other intangible assets
(800 )
(831 )
(1,620 )
(1,677 )
Free cash flow
$ 5,748
$ 5,415
$ 8,127
$ 9,058
Net cash used in investing activities 1
$ (2,006 )
$ (1,993 )
$ (3,238 )
$ (3,503 )
Net cash provided by (used in) financing activities
$ 4,474
$ (1,762 )
$ 2,324
$ (3,694 )
1. Net
cash used in investing activities includes payments for acquisitions, purchases of property and equipment and capitalized software and
other intangible assets. Purchases of property and equipment and capitalized software and other intangible assets are included in our
computation of free cash flow.
9
Explanation
of Non-GAAP Financial Measures
We
report our financial results in accordance with accounting principles generally accepted in the United States of America, or GAAP. However,
management believes that, in order to properly understand our short-term and long-term financial and operational trends, investors may
wish to consider the impact of certain non-cash or non-recurring items, when used as a supplement to financial performance measures in
accordance with GAAP. These items result from facts and circumstances that vary in frequency and impact on continuing operations. Management
also uses results of operations before such items to evaluate the operating performance of CareCloud and compare it against past periods,
make operating decisions and serve as a basis for strategic planning. These non-GAAP financial measures provide management with additional
means to understand and evaluate the operating results and trends in our ongoing business by eliminating certain non-cash expenses and
other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure
trends in ongoing operations, or reduce management’s ability to make useful forecasts. Management believes that these non-GAAP
financial measures provide additional means of evaluating period-over-period operating performance. In addition, management understands
that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing
this performance to our peers and competitors.
Management
uses adjusted EBITDA, adjusted operating income, adjusted operating margin, and non-GAAP adjusted net income to provide an understanding
of aspects of operating results before the impact of investing and financing charges and income taxes. Adjusted EBITDA may be useful
to an investor in evaluating our operating performance and liquidity because this measure excludes non-cash expenses as well as expenses
pertaining to investing or financing transactions. Management defines “adjusted EBITDA” as the sum of GAAP net income before provision for income taxes, net interest expense, other (income) expense, stock-based compensation expense, depreciation
and amortization, integration costs, transaction costs, and change in contingent consideration.
Management
defines “non-GAAP adjusted operating income” as the sum of GAAP operating income before stock-based compensation expense,
amortization of purchased intangible assets, integration costs, transaction costs, and change in contingent consideration,
and “non-GAAP adjusted operating margin” as non-GAAP adjusted operating income divided by net revenue.
Management
defines “non-GAAP adjusted net income” as the sum of GAAP net income before stock-based compensation expense, amortization
of purchased intangible assets, other (income) expense, integration costs, transaction costs, change in contingent
consideration, any tax impact related to these preceding items and income tax expense related to goodwill, and “non-GAAP adjusted
net income per share” as non-GAAP adjusted net income divided by common shares outstanding at the end of the period, including
the shares which were issued but are subject to forfeiture and considered contingent consideration.
Management
considers all of these non-GAAP financial measures to be important indicators of our operational strength and performance of our business
and a good measure of our historical operating trends, in particular the extent to which ongoing operations impact our overall financial
performance.
In
addition to items routinely excluded from non-GAAP EBITDA, management excludes or adjusts each of the items identified below from the
applicable non-GAAP financial measure referenced above for the reasons set forth with respect to that excluded item:
Foreign
exchange loss/other expense. Other expense is excluded because foreign currency gains and losses and other non-operating expenses
are expenditures that management does not consider part of ongoing operating results when assessing the performance of our business,
and also because the total amount of the expense is partially outside of our control. Foreign currency gains and losses are based on
global market factors which are unrelated to our performance during the period in which the gains and losses are recorded.
Stock-based
compensation expense. Stock-based compensation expense is excluded because this is primarily a non-cash expenditure that management
does not consider part of ongoing operating results when assessing the performance of our business, and also because the total amount
of the expenditure is partially outside of our control because it is based on factors such as stock price, volatility, and interest rates,
which may be unrelated to our performance during the period in which the expenses are incurred.
10
Amortization
of purchased intangible assets. Purchased intangible assets are amortized over their estimated useful lives and generally cannot
be changed or influenced by management after the acquisition. Accordingly, this item is not considered by management in making operating
decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which
such charges are recorded.
Contingent
consideration. Contingent consideration represents the portion of consideration payable to the seller of some of our acquisitions,
the amount of which is based on the achievement of defined performance measures contained in the purchase agreements. Contingent consideration
is adjusted to fair value at the end of each reporting period. Management does not believe such charges accurately reflect the performance
of our ongoing operations for the period in which such charges are incurred.
Transaction
costs. Transaction costs are upfront costs related to acquisitions and related transactions, such as brokerage fees, pre-acquisition
accounting costs and legal fees, and other upfront costs related to specific transactions. Management believes that such expenses do
not have a direct correlation to future business operations, and therefore, these costs are not considered by management in making operating
decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which
such charges are incurred.
Integration
costs. Integration costs are severance payments for certain employees relating to our acquisitions and exit costs related to terminating
leases and other contractual agreements. Accordingly, management believes that such expenses do not have a direct correlation to future
business operations, and therefore, these costs are not considered by management in making operating decisions. Management does not believe
such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
Restructuring
costs. Restructuring costs primarily consist of severance and separation costs associated with the optimization of the Company’s
operations and profitability improvements. Management believes that such expenses do not have a direct correlation to future business
operations, and therefore, these costs are not considered by management in making operating decisions. Management does not believe such
charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
Income
tax expense related to goodwill. Income tax expense resulting from the amortization of goodwill related to our acquisitions represents
a charge to record the tax effect resulting from amortizing goodwill over 15 years for tax purposes. Goodwill is not amortized for GAAP
reporting. This expense is not anticipated to result in a cash payment.
Free
cash flow. Management believes that free cash flow, which measures our ability to generate additional cash from our business operations,
is an important financial measure for use in evaluating the Company’s financial performance. Free cash flow should be considered
in addition to, rather than as a substitute for, consolidated net operating results as a measure of our performance and net cash provided
by operating activities as a measure of our liquidity. Additionally, the Company’s definition of free cash flow is limited, in
that it does not represent residual cash flows available for discretionary expenditures, due to the fact that the measure does not deduct
the payments required for debt service and other contractual obligations or payments made for business acquisitions. Therefore, we believe
it is important to view free cash flow as a measure that provides supplemental information to our condensed consolidated statements of
cash flows.
11
EX-99.2
EX-99.2
Filename: ex99-2.htm · Sequence: 3
Exhibit 99.2
GRAPHIC
GRAPHIC
Filename: ex99-2_001.jpg · Sequence: 4
Binary file (165719 bytes)
Download ex99-2_001.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_002.jpg · Sequence: 5
Binary file (374364 bytes)
Download ex99-2_002.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_003.jpg · Sequence: 6
Binary file (146316 bytes)
Download ex99-2_003.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_004.jpg · Sequence: 7
Binary file (157002 bytes)
Download ex99-2_004.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_005.jpg · Sequence: 8
Binary file (147010 bytes)
Download ex99-2_005.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_006.jpg · Sequence: 9
Binary file (262628 bytes)
Download ex99-2_006.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_007.jpg · Sequence: 10
Binary file (274063 bytes)
Download ex99-2_007.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_008.jpg · Sequence: 11
Binary file (103248 bytes)
Download ex99-2_008.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_009.jpg · Sequence: 12
Binary file (161415 bytes)
Download ex99-2_009.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_010.jpg · Sequence: 13
Binary file (183409 bytes)
Download ex99-2_010.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_011.jpg · Sequence: 14
Binary file (174332 bytes)
Download ex99-2_011.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_012.jpg · Sequence: 15
Binary file (183282 bytes)
Download ex99-2_012.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_013.jpg · Sequence: 16
Binary file (200527 bytes)
Download ex99-2_013.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_014.jpg · Sequence: 17
Binary file (169523 bytes)
Download ex99-2_014.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_015.jpg · Sequence: 18
Binary file (200356 bytes)
Download ex99-2_015.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_016.jpg · Sequence: 19
Binary file (157656 bytes)
Download ex99-2_016.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_017.jpg · Sequence: 20
Binary file (114835 bytes)
Download ex99-2_017.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_018.jpg · Sequence: 21
Binary file (103215 bytes)
Download ex99-2_018.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_019.jpg · Sequence: 22
Binary file (160444 bytes)
Download ex99-2_019.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_020.jpg · Sequence: 23
Binary file (139474 bytes)
Download ex99-2_020.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_021.jpg · Sequence: 24
Binary file (41772 bytes)
Download ex99-2_021.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_022.jpg · Sequence: 25
Binary file (163694 bytes)
Download ex99-2_022.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_023.jpg · Sequence: 26
Binary file (151008 bytes)
Download ex99-2_023.jpg
GRAPHIC
GRAPHIC
Filename: ex99-2_024.jpg · Sequence: 27
Binary file (163316 bytes)
Download ex99-2_024.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 32
v3.26.1
Cover
Aug. 06, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
Aug. 06, 2026
Entity File Number
001-36529
Entity Registrant Name
CARECLOUD,
INC.
Entity Central Index Key
0001582982
Entity Tax Identification Number
22-3832302
Entity Incorporation, State or Country Code
DE
Entity Address, Address Line One
7
Clyde Road
Entity Address, City or Town
Somerset
Entity Address, State or Province
NJ
Entity Address, Postal Zip Code
08873
City Area Code
(732)
Local Phone Number
873-5133
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common
Stock, par value $0.001 per share
Trading Symbol
CCLD
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration